The Latest “Buzz on the Street” Show: Featuring Pressure Biosciences Inc. (OTCQB: PBIO) Coverage

Published on: 28 Feb, 2019


FinancialBuzz.com’s latest Buzz on the Street Show: Featuring Our Corporate News Recap on “Pressure BioSciences Makes CBD Oil Water Soluble, Offering Solution to CBD Absorption Issue in Food & Beverages” and “Scientific Analyses Confirm Important Benefits from Processing CBD Oil with Pressure BioSciences’ Proprietary Ultra Shear Technology Platform”

Pressure BioSciences, Inc. (OTCQB: PBIO) on the 13th, released a short video demonstrating the Company’s proprietary Ultra Shear Technology (USTTM) platform and its ability to create extremely small, nanometer-scale oil droplets that effectively dissolve in water (nanoemulsions) to provide optimized bioavailability for absorption.

Pressure BioSciences, Inc. announced that analytical testing on hemp-derived CBD oil processed via PBI’s Ultra Shear Technology™ platform has confirmed that UST processing uniquely achieves the challenging criteria for creating highly-effective “nanoemulsions” of CBD oil in water, without loss or modification of CBD throughout the entire UST process.

Pressure BioSciences, Inc. is a leader in the development & sale of innovative, enabling, pressure-based platform solutions for the worldwide life sciences industry. Their products/services are based on three patented, pressure-enhanced platforms: Pressure Cycling Technology, Pressure Enabled Protein Manufacturing Technology, and Ultra Shear Technology.

In the past few decades, medical institutions had begun to use cannabis a form of treatment, as a result of its multifarious therapeutic effects. Researchers have conducted years of studies in order to understand the plant and its effects further. Positive results have thus allowed the integration of cannabis into medical facilities, but it also helped propel the global legalization efforts. The active components in cannabis, THC and CBD, are linked to possessing beneficial effects on the body, which make them popular options for treatment. Currently, cannabis is predominately being used to treat mild to severe medical conditions such as chronic pain, cancer, epilepsy, and seizures. And according to data compiled by Acute Market Reports, the global medical marijuana market was valued at USD 13.9 Billion in 2017 and is expected to reach USD 57.58 Billion by 2026. Additionally, the market is projected to expand at a healthy CAGR of 17.1% throughout the forecast period from 2018 to 2026. Dispensaries are expected to flourish during the period because they offer a wide range of products, including remedies to treat pain even though medical institutions may look to use certain biotechnology or pharmaceutical manufacturers’ products to treat more severe conditions. With the rates of medical cases like cancer continually rising year over year, it is projected that the demand for medical cannabis will increase throughout the period as well.      

North America is the global leader in the medical cannabis industry, primarily due to its rising prevalence of cancer and proactive policies. Canada has fully legalized cannabis entirely, while the U.S. boasts just over 30 states that have adopted cannabis for medical use. The U.S. is the largest cannabis market globally despite not having legalized cannabis entirely on a federal scale. However, ongoing legalization efforts have made regulations regarding the plant much more lenient. Regulations have allowed manufacturers to produce cannabis not only in forms of flower, but also in different variations like capsules, tinctures, creams, and even oils. On the other hand, federal regulations regarding THC are still heavily enforced around theU.S. CBD, though, is completely legalized because of its non-psychoactive effects. “CBD can supplement a depleted ECS system by working to ease the unfriendly symptoms in the body with the goal to help the body achieve homeostasis, or balance. Just like our body produces calcium, and some people take calcium supplements, we can use CBD in the same way,” said Tisha Trautsch,  RN, BSN, who recently led a course on about the history, products and potential benefits of CBD, “This isn’t a cure, it’s a supplement. But it is very up-and-coming. It’s coming hard and it’s coming fast.”

For more information, please visit: Pressure Biosciences, Inc.

For more corporate news on Pressure Biosciences Inc., check out the Buzz on the Street

About Buzz on the Street: One of FinancialBuzz.com’s latest corporate and financial news shows, covering the latest trending stock market news. Buzz on the Street looks to become a leader in corporate video news dissemination. Buzz on the Street is 100% original content, brought to you by Financial Buzz Media.

Ratings

Ratings
  • 708Views
  • 0Comments

Recommend to Friends

  • facebook
  • Twitter
  • google plus
  • pinterest
  • Digg
  • stumbleupon
  • Reddit
  • linkedin

Carlos Braadt

Email: Carlos@financialinsiders.com

@Newsletter

Sign Up for Weekly Updates

Opt-into our eNewsletter NOW! For the Latest Trending Financial News Topics in Cannabis, Tech, Biotechs, Precious Metals, Energy, Renewable Energy and much more!

Related Posts

07 Jun, 2017 1043
21 Jun, 2017 1907
14 Jul, 2017 917
20 Sep, 2017 832

Comments

There is no comment on this article